Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
Abstract Background Targeted deprescribing of anticholinergic and sedative medications in older people may improve their health outcomes. This trial will determine if pharmacist-led reviews lead to general practitioners deprescribing anticholinergic and sedative medications in older people living in...
Enregistré dans:
Auteurs principaux: | Ulrich Bergler, Nagham J. Ailabouni, John W. Pickering, Sarah N. Hilmer, Dee Mangin, Prasad S. Nishtala, Hamish Jamieson, Sponsor-investigator |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/71fc7b0c3b4f475abce3526a7e771268 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Understanding Stakeholder Views Regarding the Design of an Intervention Trial to Reduce Anticholinergic Burden: A Qualitative Study
par: Yvonne Cunningham, et autres
Publié: (2021) -
Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study
par: Alrasheed MM, et autres
Publié: (2018) -
Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial
par: Damien Cateau, et autres
Publié: (2021) -
Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial
par: Marc-Eric Nadeau, et autres
Publié: (2021) -
Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life
par: Stefano Rizza, et autres
Publié: (2021)